Hong Kong Consumer Finance Stock News

In April 2026, ASMPT Limited reported first-quarter 2026 sales of HK$3,966.8 million and net income of HK$253.82 million, and later issued second-quarter 2026 revenue guidance of US$540 million to US$600 million, with the midpoint exceeding prior market expectations and largely driven by its SEMI segment. This combination of stronger recent earnings and guidance that outpaces consensus highlights how ASMPT’s semiconductor equipment operations, particularly SEMI, are gaining operational...

Regulatory milestones put Hansoh Pharmaceutical Group (SEHK:3692) pipeline in focus Hansoh Pharmaceutical Group (SEHK:3692) has reported two fresh milestones from China’s National Medical Products Administration, including Breakthrough-Therapy-Designated Drug status for its oncology candidate HS-20093 and new clinical trial approvals for hypertension therapy HS-10522. See our latest analysis for Hansoh Pharmaceutical Group. Despite the regulatory momentum, Hansoh Pharmaceutical Group’s share...

Sales update puts China Power International Development in focus China Power International Development (SEHK:2380) has drawn investor attention after reporting that electricity sold in March 2026 and for the year to date was lower than in the same periods a year earlier. For March, the Group sold 10,528,146 MWh of electricity compared with 10,961,682 MWh a year before, while year to date sales were 29,120,047 MWh versus 30,747,663 MWh for the same period last year. See our latest analysis for...

Luk Fook Holdings (International) (SEHK:590) released its fourth quarter sales update, highlighting year-on-year growth in overall RSV, retail revenue and same store sales, with weight-based gold products standing out as international gold prices climbed. See our latest analysis for Luk Fook Holdings (International). The fourth quarter sales update comes after a mixed share price run, with the latest close at HK$22.9, a 1 year share price return of 37.41% total shareholder return, and weaker...

East Buy Holding (SEHK:1797) has drawn investor attention recently as its share price performance has differed between the past month and past 3 months, prompting a closer look at its livestreaming e-commerce business fundamentals. See our latest analysis for East Buy Holding. At a latest share price of HK$25.88, East Buy Holding has seen a 14.19% 1 month share price decline and an 8.42% 3 month share price decline. However, its year to date share price return of 43.06% and 1 year total...

BYD Company Limited ( HKG:1211 ) recently posted soft earnings but shareholders didn't react strongly. We did some...

Special dividend and auditor reappointment set the stage Yixin Group (SEHK:2858) approved a special dividend of HK$0.04 per share at its April 23, 2026 AGM, and also reappointed PricewaterhouseCoopers as auditor, putting corporate actions and capital returns in focus for shareholders. See our latest analysis for Yixin Group. At a share price of HK$1.92, Yixin Group has a 1-day share price return of 1.59%, but a 30-day share price return of an 11.52% decline and a 90-day share price return of...

Q1 2026 results and why they matter for Weichai Power (SEHK:2338) Weichai Power (SEHK:2338) has drawn fresh attention after reporting first quarter 2026 earnings, with higher sales, revenue and net income compared with a year earlier, and earnings per share of CN¥0.36 from continuing operations. See our latest analysis for Weichai Power. Investors have reacted strongly to the Q1 2026 update, with the share price at HK$43.32 and a 30 day share price return of 48.87%, contributing to a 1 year...

Insiders were net buyers of Regal Partners Holdings Limited's ( HKG:1575 ) stock during the past year. That is...

While FIT Hon Teng Limited ( HKG:6088 ) might not have the largest market cap around , it saw a significant share price...

Xinyuan Property Management Service (Cayman) Ltd.'s ( HKG:1895 ) recent earnings report didn't offer any surprises...

Last week's profit announcement from AAC Technologies Holdings Inc. ( HKG:2018 ) was underwhelming for investors...

The market seemed underwhelmed by last week's earnings announcement from Kerry Properties Limited ( HKG:683 ) despite...

Profit growth, valuation gap and what they might mean for Mobvista Recent coverage of Mobvista (SEHK:1860) has focused on its significant profit growth and higher revenue from Advertising Technology Services and Marketing Technology Business, alongside a share price that trades below some estimated fair value measures. See our latest analysis for Mobvista. Mobvista's latest close at HK$17.75 follows a sharp 8.9% 1 day share price return and a 34.88% 30 day share price return. The 1 year total...

Governance overhaul and what it could mean for Legend Holdings shareholders Legend Holdings (SEHK:3396) is overhauling its governance framework by planning to abolish the Board of Supervisors, shift oversight duties to the Audit Committee, and revise its Articles of Association and meeting procedures. See our latest analysis for Legend Holdings. Legend Holdings' governance reset lands after a strong 15.15% 30-day share price return and 13.80% 90-day share price return. The 1-year total...

Shareholders appeared unconcerned with Best Mart 360 Holdings Limited's ( HKG:2360 ) lackluster earnings report last...

Unity Group Holdings International Limited ( HKG:1539 ) insiders who purchased shares in the last 12 months were richly...

As Asia's markets navigate a landscape marked by geopolitical tensions and economic resilience, investors are increasingly looking towards growth companies with substantial insider ownership as potential opportunities. In this context, stocks with high insider stakes can offer insights into management confidence and alignment of interests, making them particularly appealing amidst the region's evolving economic conditions.

As global markets navigate the complexities of central bank policies and geopolitical tensions, Asia's financial landscape remains a focal point for investors seeking growth opportunities. Penny stocks, often associated with smaller or newer companies, continue to capture attention due to their potential for significant returns when backed by solid fundamentals. Despite being a somewhat outdated term, these stocks offer intriguing prospects for those looking to uncover hidden value in the...

Why Shanghai Fudan Microelectronics Group’s Latest Earnings Matter Shanghai Fudan Microelectronics Group (SEHK:1385) has just released first quarter 2026 results, reporting revenue of CNY 1,032.05 million and net income of CNY 148.31 million, both higher than the same period last year. See our latest analysis for Shanghai Fudan Microelectronics Group. The earnings release comes after a volatile stretch, with a 1 day share price return of 7.46% and a 30 day share price return of 18.64% partly...

Q1 production update and why it matters for investors CGN Mining (SEHK:1164) has drawn fresh attention after reporting first quarter 2026 operating results, with total natural uranium production output of 580.9 tU. This gives investors new detail on the company’s current operating scale. See our latest analysis for CGN Mining. The Q1 production update comes as CGN Mining’s share price sits at HK$4.05, with a 1 day share price return of 4.11% but a 90 day share price return decline of 14.19%...

RoboNeo update puts Meitu’s AI content tools in focus Meitu (SEHK:1357) recently announced a major upgrade to its RoboNeo imaging AI agent, introducing an Agent Teams model that uses multiple specialized agents to manage content creation workflows end to end. This product update centers on Multi-Agent Orchestration, where roles such as Director, Scriptwriter, and Visual Editor work together in real time to reduce tool switching, address content sameness, and support users across social media,...

CSPC Pharmaceutical Group recently reported several oncology milestones, including U.S. FDA clearance for SYH2095 clinical trials and strong Phase Ib/III results for its sirolimus injection HB1901 in advanced malignant PEComa, alongside proposed updates to its articles of association to support hybrid and virtual shareholder meetings. With first-in-class epigenetic and novel sirolimus-based therapies progressing and antibody-drug conjugate SYS6051 entering trials in both the U.S. and China,...

HSBC Global Research recently highlighted Seazen Group (SEHK:1030) as a top pick among Chinese property developers after Shenzhen relaxed home purchase restrictions, drawing attention to how supportive policies could affect the stock. See our latest analysis for Seazen Group. Seazen Group’s share price at HK$2.21 has seen a 7 day share price return of 5.74% and a 30 day share price return of 6.76%. However, the 90 day share price return of 13.33% and 5 year total shareholder return of 70.91%...